Angiotensin II stimulates sympathetic neurotransmission to adipose tissue

Physiological Reports

Volumn 1, Issue 2, 2013, Pages

  King, Victoria L ^a   English, Victoria L ^a   Bharadwaj, Kalyani ^b   Cassis, Lisa A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Piramal Enterprises Limited   (India)

Author keywords

Body weight; Catecholamine turnover; Norepinephrine

Indexed keywords

ANGIOTENSIN II; METIROSINE; NISOXETINE; NORADRENALIN; NORADRENALIN TRANSPORTER; PROPRANOLOL; SODIUM CHLORIDE; TYROSINE 3 MONOOXYGENASE;

ADIPOSE TISSUE; ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FLUID INTAKE; FOOD INTAKE; HEART LEFT VENTRICLE; MALE; NONHUMAN; OSMOTIC MINIPUMP; RAT; SPECTROPHOTOMETRY; SYSTOLIC BLOOD PRESSURE; TURNOVER TIME; WEIGHT REDUCTION;

EID: 85008877332     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.1002/phy2.14     Document Type: Article

References (46)

1. Asbert, M., W. Jimenez, J. Gaya, P. Gines, V. Arroyo, F. Rivera, et al. 1992. Assessment of the renin-angiotensin system in cirrhotic patients. Comparison between plasma renin activity and direct measurement of immunoreactive renin. J. Hepatol. 15: 179–183.
2. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248–254.
3. Brink, M., J. Wellen, and P. Delafontaine. 1996. Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. J. Clin. Invest. 97: 2509–2516.
4. Brink, M., S. R. Price, J. Chrast, J. L. Bailey, A. Anwar, W. E. Mitch, et al. 2001. Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. Endocrinology 142: 1489–1496.
5. Brito, N. A., M. N. Brito, and T. J. Bartness. 2008. Differential sympathetic drive to adipose tissues after food deprivation, cold exposure or glucoprivation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294: R1445–R1452.
6. Brodie, B. B., E. Costa, A. Dlabac, N. H. Neff, and H. H. Smookler. 1966. Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines. J. Pharmacol. Exp. Ther. 154: 493–498.
7. Burke, S. L., G. A. Head, G. W. Lambert, and R. G. Evans. 2007. Renal sympathetic neuroeffector function in renovascular and angiotensin II-dependent hypertension in rabbits. Hypertension 49: 932–938.
8. Cassis, L. A. 1993. Role of angiotensin II in brown adipose thermogenesis during cold acclimation. Am. J. Physiol. 265: E860–E865.
9. Cassis, L. A. 1994. Angiotensin II in brown adipose tissue from young and adult Zucker obese and lean rats. Am. J. Physiol. 266: E453–E458.
10. Cassis, L. A., K. R. Lynch, and M. J. Peach. 1988a. Localization of angiotensinogen messenger RNA in rat aorta. Circ. Res. 62: 1259–1262.
11. Cassis, L. A., J. Saye, and M. J. Peach. 1988b. Location and regulation of rat angiotensinogen messenger RNA. Hypertension 11: 591–596.
12. Cassis, L. A., R. E. Stitzel, and R. J. Head. 1988c. Influence of cold-induced increases in sympathetic nerve activity on norepinephrine content in the vasculature of the spontaneously hypertensive rat. Blood Vessels 25: 82–88.
13. Cassis, L., A. Laughter, M. Fettinger, S. Akers, R. Speth, G. Burke, et al. 1998a. Cold exposure regulates the renin-angiotensin system. J. Pharmacol. Exp. Ther. 286: 718–726.
14. Cassis, L. A., D. E. Marshall, M. J. Fettinger, B. Rosenbluth, and R. A. Lodder. 1998b. Mechanisms contributing to angiotensin II regulation of body weight. Am. J. Physiol. 274: E867–E876.
15. Cassis, L., M. Helton, V. English, and G. Burke. 2002. Angiotensin II regulates oxygen consumption. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282: R445–R453.
16. Cassis, L. A., S. B. Police, F. Yiannikouris, and S. E. Thatcher. 2008. Local adipose tissue renin-angiotensin system. Curr. Hypertens. Rep. 10: 93–98.
17. Dwoskin, L. P., A. L. Jewell, and L. A. Cassis. 1992. DuP 753, a nonpeptide angiotensin II-1 receptor antagonist, alters dopaminergic function in rat striatum. Naunyn Schmiedebergs Arch. Pharmacol. 345: 153–159.
18. English, V., and L. Cassis. 1999. Facilitation of sympathetic neurotransmission contributes to angiotensin regulation of body weight. J. Neural Transm. 106: 631–644.
19. Granneman, J. G. 1995. Why do adipocytes make the beta 3 adrenergic receptor? Cell. Signal. 7: 9–15.
20. Henegar, J. R., G. L. Brower, A. Kabour, and J. S. Janicki. 1995. Catecholamine response to chronic Ang II infusion and its role in myocyte and coronary vascular damage. Am. J. Physiol. 269: H1564–H1569.
21. Kawasaki, H., W. H. Cline Jr., and C. Su. 1982. Enhanced angiotensin-mediated facilitation of adrenergic neurotransmission in spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 221: 112–116.
22. King, V. L., L. P. Dwoskin, and L. A. Cassis. 1999. Cold exposure regulates the norepinephrine uptake transporter in rat brown adipose tissue. Am. J. Physiol. 276: R143–R151.
23. Kline, R. L., K. Y. Chow, and P. F. Mercer. 1990. Does enhanced sympathetic tone contribute to angiotensin II hypertension in rats? Eur. J. Pharmacol. 184: 109–118.
24. Kurz, T., R. Tolg, and G. Richardt. 1997. Bradykinin B2-receptor-mediated stimulation of exocytotic noradrenaline release from cardiac sympathetic neurons. J. Mol. Cell. Cardiol. 29: 2561–2569.
25. McPherson, G. A. 1983. A practical computer-based approach to the analysis of radioligand binding experiments. Comput. Programs Biomed. 17: 107–113.
26. Meldrum, M. J., C. S. Xue, L. Badino, and T. C. Westfall. 1984. Angiotensin facilitation of noradrenergic neurotransmission in central tissues of the rat: effects of sodium restriction. J. Cardiovasc. Pharmacol. 6: 989–995.
27. Migliorini, R. H., M. A. Garofalo, and I. C. Kettelhut. 1997. Increased sympathetic activity in rat white adipose tissue during prolonged fasting. Am. J. Physiol. 272: R656–R661.
28. Nahmias, C., N. Blin, J. M. Elalouf, M. G. Mattei, A. D. Strosberg, and L. J. Emorine. 1991. Molecular characterization of the mouse beta 3-adrenergic receptor: relationship with the atypical receptor of adipocytes. EMBO J. 10: 3721–3727.
29. Peach, M. J. 1981. Molecular actions of angiotensin. Biochem. Pharmacol. 30: 2745–2751.
30. Pedersen, E. B., H. Danielsen, T. Jensen, M. Madsen, S. S. Sorensen, and O. O. Thomsen. 1986. Angiotensin II, aldosterone and arginine vasopressin in plasma in congestive heart failure. Eur. J. Clin. Invest. 16: 56–60.
31. Phillips, M. I., E. A. Speakman, and B. Kimura. 1993. Levels of angiotensin and molecular biology of the tissue renin angiotensin systems. Regul. Pept. 43: 1–20.
32. Putnam, K., F. Batifoulier-Yiannikouris, K. G. Bharadwaj, E. Lewis, M. Karounos, A. Daugherty, et al. 2012. Deficiency of angiotensin type 1a receptors in adipocytes reduces differentiation and promotes hypertrophy of adipocytes in lean mice. Endocrinology 153: 4677–4786.
33. Raizada, M. K., D. Lu, H. Yang, and K. Yu. 1996. AT1-receptors and cellular actions of angiotensin II in neuronal cultures of stroke prone-spontaneously hypertensive rat brain. Adv. Exp. Med. Biol. 396: 71–78.
34. Ramchandra, R., S. G. Hood, A. M. Watson, A. M. Allen, and C. N. May. 2012. Central angiotensin type 1 receptor blockade decreases cardiac but not renal sympathetic nerve activity in heart failure. Hypertension 59: 634–641.
35. Ran, J., T. Hirano, and M. Adachi. 2005. Angiotensin II infusion increases hepatic triglyceride production via its type 2 receptor in rats. J. Hypertens. 23: 1525–1530.
36. Rezk, B. M., T. Yoshida, L. Semprun-Prieto, Y. Higashi, S. Sukhanov, and P. Delafontaine. 2012. Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy. PLoS ONE 7: e30276.
37. Shenoy, U., and L. Cassis. 1997. Characterization of renin activity in brown adipose tissue. Am. J. Physiol. 272: C989–C999.
38. Staroukine, M., J. Devriendt, P. Decoodt, and A. Verniory. 1984. Relationships between plasma epinephrine, norepinephrine, dopamine and angiotensin II concentrations, renin activity, hemodynamic state and prognosis in acute heart failure. Acta Cardiol. 39: 131–138.
39. Storgaard, T., and O. A. Nedergaard. 1997. Prejunctional modulation by angiotensins of noradrenaline release from sympathetic neurons in isolated rabbit aorta. Naunyn Schmiedebergs Arch. Pharmacol. 356: 706–711.
40. Tejani-Butt, S. M. 1992. [3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding. J. Pharmacol. Exp. Ther. 260: 427–436.
41. Thatcher, S., F. Yiannikouris, M. Gupte, and L. Cassis. 2009. The adipose renin-angiotensin system: role in cardiovascular disease. Mol. Cell. Endocrinol. 302: 111–117.
42. Wernze, H., H. J. Spech, and G. Muller. 1978. Studies on the activity of the renin-angiotensin-aldosterone system (RAAS) in patients with cirrhosis of the liver. Klin. Wochenschr. 56: 389–397.
43. Wilson, C., S. Wilson, V. Piercy, M. V. Sennitt, and J. R. Arch. 1984. The rat lipolytic beta-adrenoceptor: studies using novel beta-adrenoceptor agonists. Eur. J. Pharmacol. 100: 309–319.
44. Yang, H., and M. K. Raizada. 1998. MAP kinase-independent signaling in angiotensin II regulation of neuromodulation in SHR neurons. Hypertension 32: 473–481.
45. Yiannikouris, F., M. Gupte, K. Putnam, S. Thatcher, R. Charnigo, D. L. Rateri, et al. 2012. Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice. Hypertension 60: 1524–1530.
46. Yu, K., D. Lu, N. E. Rowland, and M. K. Raizada. 1996. Angiotensin II regulation of tyrosine hydroxylase gene expression in the neuronal cultures of normotensive and spontaneously hypertensive rats. Endocrinology 137: 3566–3576.